Rivaroxaban als effektive Therapieoption der Livedovaskulopathie
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
The livedoid vasculopathy is a rare disease caused by thromboembolic occlusion of small and medium vessels in the superficial dermal plexus. Immunosuppressive treatment was often ineffective and resulted in a refractory disease cause. The efficiency of anticoagulants in the treatment of the disease was described a couple of years ago. Here, we report successful treatment with rivaroxaban and fast achievement of remission in a 30-year-old patient with livedoid vasculopathy.
Translated title of the contribution | Rivaroxaban as an Effective Treatment of Livedoid Vasculopathy |
---|
Details
Original language | German |
---|---|
Pages (from-to) | 199-201 |
Number of pages | 3 |
Journal | Aktuelle Dermatologie |
Volume | 43 |
Issue number | 5 |
Publication status | Published - 1 May 2017 |
Peer-reviewed | Yes |
External IDs
ORCID | /0000-0002-8217-6872/work/152545006 |
---|---|
ORCID | /0000-0002-2164-4644/work/152545843 |
ORCID | /0000-0002-4330-1861/work/152544350 |